On August 7, Axon Enterprise, Inc. rose 5.03% in regular trading, trading at $548.85/share, with turnover of $254 million. The rebound followed Morgan Stanley's research note affirming the quality of the company's Q2 earnings after the stock had been dragged lower by a broad AI software sector selloff.

Morgan Stanley stated that Axon delivered \"clean\" Q2 results, with $15.1 billion in future contracted bookings meeting expectations, signaling a healthy underlying demand environment. The firm now expects Axon to deliver revenue growth of 33% in 2026 and 34% in 2027, citing continued traction across its broader product portfolio including counter-drone and international markets. Q2 revenue came in at $904.4 million, up 35.3% year-over-year, exceeding the consensus estimate of $876.4 million. The company also raised its full-year revenue growth guidance to 32%-34%, up from 30%-32% previously.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)